biohavenpharma.com (BHVN) Tezkor likvidlik koeffitsiyenti
Biohaven Ltd. (BHVN) uchun ushbu narxlar grafigi, qaysiki asosiy aktivlarni baholashga yordam beradi, muvaffaqiyati epilepsiya dori vositalari sinovlari natijalariga bog'liq bo'lgan kompaniya dinamikasini aks ettiradi, bunda ko'rsatkich 4.52 darajasida turibdi. Patentlar va shifokorlar bilan aloqa xarajatlari bozorga kirish uchun yuqori to'siqni ta'minlaydi. Biznes huquqlarni sanoat gigantlariga o'tkazish va ishlab chiqarishni autsorsing qilish orqali kengayadi, ilmiy tadqiqotlarni yuqori daromadga aylantiradi.
%20Tezkor%20likvidlik&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_BHVN_-_Biohaven-Ltd._-_Quick-Liquidity "Biohaven Pharmaceutical (BHVN) - Tezkor likvidlik koeffitsiyenti 04.07.2022dan 29.10.2026gacha | 👁️GURU.Markets👁️")
biohavenpharma.com (BHVN) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Biohaven Ltd.|BHVN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Biohaven|BHVN - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Biohaven Pharmaceutical|BHVN - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzlari Biohaven|Tezkor likvidlik biohavenpharma.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning dastlabki tahlili:Biohaven Pharmaceutical, BHVN
Klinik sinovlar va FDA tasdiqlashiga yo'naltirilgan kapital xarajatlar sur'atini nazorat qilish Biohaven Ltd. (BHVN) uchun juda muhimdir. GURU.Markets platformasidagi tezkor koeffitsient (quick ratio) ko'rsatkichlari tarixini tahlil qilish orqali investor naqd pul va debitorlik qarzdorligining zaxiralarni istisno qilgan holda joriy majburiyatlarga nisbatini ko'rishi mumkin, bu esa aktivlarni sotmasdan, yuqori naqd pul sarfi sharoitida kompaniyaning qarzlarni to'lash qobiliyatini baholash imkonini beradi.
Toʻgʻridan-toʻgʻri raqobatchilar
Biogen Corp (BIIB) - Tezkor likvidlik|Shoshilinch likvidlik Neurocrine Corp (NBIX)|RGC (Regencell Bioscience) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik AXSM|Tezkor likvidlik koeffitsiyenti ACAD|Oraliq qoplama koeffitsiyenti Xenon Pharmaceuticals Inc.|Tezkor likvidlik Viking Pharma VKTX|Supernus Corp (SUPN) - Shoshilinch likvidlik|Catalyst Pharmaceuticals - Tezkor likvidlik koeffitsiyenti|Oraliq qoplash koeffitsiyenti DNLI (denalitherapeutics.com)|HRMY: Tezkor likvidlik koeffitsiyenti|Amylyx Pharmaceuticals Inc (AMLX) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi TRVI|Tezkor likvidlik PRAX|Tezkor likvidlik koeffitsiyenti AVXL|CBLL - Shoshilinch likvidlik|Tezkor likvidlik Prothena Corporation PLC PRTA|ALEC: Shoshilinch likvidlik koeffitsiyenti|ANNX: Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti OMER (Omeros Corporation)|Neurogene Inc. (NGNE) - Tezkor likvidlik|ACIU (acimmune.com) - Tezkor likvidlik|Tezkor likvidlik ko‘rsatkichi VYGR|NMRA (Neumora) - Oraliq likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti SCLX|Tevogen Bio Inc. - Shoshilinch likvidlik koeffitsiyenti|Alpha Cognition Inc. - Tezkor likvidlik ko‘rsatkichi|Oraliq qoplama koeffitsiyenti Cognition Therapeutics Inc. (CGTX)|Inhibikase Therapeutics, Inc. - Tezkor likvidlik koeffitsiyenti|SAVA: Tezkor likvidlik|ASRT: Tezkor likvidlik koeffitsiyenti|Coya Therapeutics - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi VTGN|Tezkor likvidlik OVID|Tezkor likvidlik Acumen Pharmaceuticals, Inc. (ABOS)|CervoMed, Inc. - Shoshilinch likvidlik koeffitsiyenti|Tezkor likvidlik Alterity Therapeutics Limited ATHE|CLNN: Shoshilinch likvidlik koeffitsiyenti|PepGen Corp - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Jupiter Neurosciences, Inc.|RLMD (Relmada Therapeutics, Inc.) - Tezkor likvidlik ko‘rsatkichi|Annovis Bio Inc (ANVS) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik Grace Therapeutics Inc|AIFF: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Klotho Neurosciences Inc (KLTO)|NRSN - Shoshilinch likvidlik|Tezkor likvidlik koeffitsiyenti RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MetaVia Inc. - Tezkor likvidlik|NeurAxis, Inc - Tezkor likvidlik koeffitsiyenti|Oraliq qoplama koeffitsiyenti Helius Medical HSDT|passagebio.com (PASG) - Tezkor likvidlik|Shoshilinch likvidlik Neuphoria Therapeutics (NEUP)|NERV (Minerva Neurosciences, Inc.) - Tezkor likvidlik koeffitsiyenti|ATHA: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik koeffitsiyenti ADXN|Tezkor likvidlik koeffitsiyenti alzamend.com (ALZN)|Cyclerion Therapeutics, Inc. - Tezkor likvidlik ko‘rsatkichi|Protagenic Therapeutics Inc. - Tezkor likvidlik|Pasithea - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Cortigent, Inc.|Avenue Therapeutics, Inc (ATXI) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti BCLI|Tezkor likvidlik ko‘rsatkichi CARA|CHRO: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Eliem Therapeutics (ELYM)|Tezkor likvidlik ITCI (intracellulartherapies.com)|Longboard Pharma - Tezkor likvidlik ko‘rsatkichi|Oraliq likvidlik koeffitsiyenti MRNS (Marinus Pharma)|NKGen Biotech, Inc. - Tezkor likvidlik koeffitsiyenti|NRBO (neurobopharma.com) - Shoshilinch likvidlik koeffitsiyenti|SAGE (Sage Therapeutics) - Tezkor likvidlik ko‘rsatkichi|SNPX - Oraliq qoplama koeffitsiyenti|TRVN (Trevena, Inc) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik VIGL|Tezkor likvidlik koeffitsiyenti WENA|CERE (cerevel.com) - Oraliq qoplash koeffitsiyenti